Jaguar Health (JAGX) Shares Up 8.3%

Jaguar Health Inc (NASDAQ:JAGX) shares shot up 8.3% during trading on Wednesday . The company traded as high as $0.14 and last traded at $0.13. 1,871,029 shares were traded during trading, an increase of 45% from the average session volume of 1,287,173 shares. The stock had previously closed at $0.12.

The company has a market capitalization of $12.76 and a P/E ratio of -0.19. The company has a current ratio of 0.26, a quick ratio of 0.15 and a debt-to-equity ratio of 0.35.

TRADEMARK VIOLATION NOTICE: “Jaguar Health (JAGX) Shares Up 8.3%” was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://theolympiareport.com/2017/12/27/jaguar-health-jagx-shares-up-8-3-3.html.

Jaguar Health Company Profile

Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with Analyst Ratings Network's FREE daily email newsletter.


 Comment on this Post

Latest News

Jaguar Health (JAGX) Shares Up 8.3%

Jaguar Health Inc (NASDAQ:JAGX) shares shot up 8.3% during trading on Wednesday . The company traded as high as $0.14 and last traded at $0.13. 1,871,029 shares were traded during trading, an increase of 45% from the average session volume of 1,287,173 shares. The stock had previously closed at $0.12.

The company has a market capitalization of $12.76 and a P/E ratio of -0.19. The company has a current ratio of 0.26, a quick ratio of 0.15 and a debt-to-equity ratio of 0.35.

TRADEMARK VIOLATION NOTICE: “Jaguar Health (JAGX) Shares Up 8.3%” was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://theolympiareport.com/2017/12/27/jaguar-health-jagx-shares-up-8-3-3.html.

Jaguar Health Company Profile

Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with Analyst Ratings Network's FREE daily email newsletter.


 Comment on this Post

Latest News